Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 35 non-cytoplasmic 36 60 transmembrane 61 93 cytoplasmic 94 119 transmembrane 120 125 non-cytoplasmic 126 144 transmembrane 145 152 cytoplasmic 153 177 transmembrane 178 202 non-cytoplasmic 203 222 transmembrane 223 233 cytoplasmic 234 256 transmembrane 257 279 non-cytoplasmic 280 311 transmembrane 312 331 cytoplasmic 332 352 transmembrane 353 357 non-cytoplasmic 358 382 transmembrane 383 396 cytoplasmic 397 413 transmembrane 414 418 non-cytoplasmic 419 437 transmembrane 438 448 cytoplasmic 449 469 transmembrane 470 475 non-cytoplasmic
Input: >PP_1002 MSDSSGKLKLGALVALVVGSMIGGGIFSLPQNMAASAGVGAVLIGWAITAVGMLTLAFVF QTLANRKPDLDGGVYAYAKAGFGDYMGFSSAWGYWISAWLGNVGYFVLLFSTLGYFFPIF GEGNTPAAIIGASILLWAVHFLVLRGIKEAAFINLVTTVAKVVPLVLFALICLFAFRLDI FTADIWAMGTPELGSVMNQVRNMMLVTVWVFIGIEGASIFSARAEKRTDVGKATVIGFVT VLLFLVLVNVLSLGIMTQPELAKLQNPSMAAVLEHVVGHWGAVLISVGLVISLLGALLSW VLLCAEIMFAAAKDHTMPEFLRRENAKQVPANALWLTNAMVQIFLVITLFSSSTYLSLIY LATSMILVPYLWSAAYAFLLALRSETYEQALAERKKDLIIGGIALLYAIWLLYAGGVKYL LLSALLYAPGAILFAKAKREVGKPVFTNVEKLIFAAVVIGALVAAYGLYDGFLTL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server